ACRV
Acrivon Therapeutics, Inc. · Healthcare
President and CEO Peter Blume-Jensen bought $82K of Acrivon Therapeutics, Inc.
Bought$82,124
$1.68Price
49,000Shares
+2%Stake
What ACRV did for a copier
- $1,000 copied at Tue, Jan 20 open, $2.05
- $824
- S&P 500, same days
- +0.5%
Measured over 30 trading days, to the Mar 4 close.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jan 14. Filed Fri, Jan 16. Returns use the Jan 20 open and the Mar 4 close. Not investment advice.